Maryland Oncology Hematology
David Weng is a seasoned oncology and hematology expert currently serving as a Partner at Maryland Oncology Hematology since October 2020. Prior to this role, David held various positions at Luminis Health from February 2014 to October 2020, where responsibilities included medical staff work in medical oncology and hematology. David's extensive experience encompasses leadership roles at TetraLogic Pharmaceuticals as Senior Vice President, Chief Medical Officer, and Vice President of Clinical Oncology from August 2009 to February 2014, as well as a role as Director at MedImmune from August 2006 to August 2009. Early career experiences include serving as Staff at Cleveland Clinic and completing an oncology fellowship at the National Cancer Institute. David completed medical residency at Johns Hopkins Hospital and holds an MD and Ph.D. in Biochemistry from The Johns Hopkins University School of Medicine, as well as an A.B. in Biochemistry from Harvard University.
This person is not in the org chart
This person is not in any teams
Maryland Oncology Hematology
Maryland Oncology Hematology was founded in 1986 by Dr. Jon Minford and was the first to provide medical oncology and hematology care to residents in the growing Howard county area of Maryland. Over the years MOH has continued to grow to become the largest community-based Oncology/Hematology practice in the state of Maryland. Currently, MOH has 13 locations and 400+ employees. Our practice locations include Columbia, Lanham, Clinton, Brandywine, Silver Spring, Laurel, Rockville, Bethesda, Germantown, Frederick, Mt. Airy, and Annapolis. Our services have also expanded beyond Oncology to include Radiation Oncology, Genetics, Clinical Research, Behavioral Health, and various surgical specialties. We currently have over 60 Physicians and Advance Practice Professionals to provide care to over 50,000 patients. Maryland Oncology Hematology is united in healing with The US Oncology Network, one of the nation’s largest community-based cancer treatment and research networks focused on advancing cancer care in America. As an affiliate of The US Oncology Network, Maryland Oncology Hematology is united with approximately 1,600 physicians and 10,000 cancer professionals nationwide. Maryland Oncology Hematology participates in clinical trials through US Oncology Research, which has helped to develop FDA approved cancer therapies.